A novel smoothened antagonist, TAK-441, delays castration-resistant progression in prostate cancer by disrupting paracrine hedgehog signaling.

作者:Ghaffari Mazyar; Ibuki Naokazu; Iu Irene; Pandey Mitali; Fazli Ladan; Kashiwagi Masahide; Tojo Hideaki; Nakanishi Osamu; Gleave Martin E; Cox Michael E
来源:104th Annual Meeting of the American-Association-for-Cancer-Research (AACR), 2013-04-06 to 2013-04-10.
DOI:10.1158/1538-7445.AM2013-4952
  • 出版日期2013-4-15

全文